FindTrial
Sign In

A retrospective study of pancreatic ductal adenocarcinomas of different molecular subtypes

A retrospective study of pancreatic ductal adenocarcinomas of different molecular subtypes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077611
Enrollment
Unknown
Registered
2023-11-14
Start date
2023-11-15
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Basal-like subtype of PDAC:N/A
classical subtype of PDAC:N/A

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Patient with a pancreatic tumour that is resectable and for which surgery has been completed ? Postoperative histopathological findings of pancreatic ductal adenocarcinoma

Exclusion criteria

Exclusion criteria: ? Patients with lost follow up ? Patients who died perioperatively due to haemorrhage, infection

Design outcomes

Primary

MeasureTime frame
overall survival;—

Secondary

MeasureTime frame
Tumor size;Tumor location ;Perineural invasion;Vascular invasion;Lymph invasion;TNM stage;age;sex;CA199;CEA;—

Countries

China

Contacts

Public ContactPeng Bing

West China Hospital of Sichuan University

z745151058@163.com+86 189 8060 1481

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026